Presentation TCT 2022 TCT 58: FANTOM II Trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Final: 5 Year Clinical Outcomes Presenter: Matthias Lutz September 17, 2022
Presentation TCT 2022 TCT 21: Preferred Strategy in the Era of Short-Term Dual Antiplatelet Therapy: A Systematic Review and Network Meta-Analysis of Randomized Trials Presenter: Toshiki Kuno September 17, 2022
Presentation TCT 2022 TCT 57: Everolimus-eluting Bioresorbable Vascular Scaffolds for Coronary Atherosclerosis Restoration Therapy: Insights on Long-term Intracoronary Imaging and Physiological Results of Bioresorption Presenter: Gabriele Pesarini September 17, 2022
Presentation TCT 2022 TCT 20: Relative benefit of double versus triple antithrombotic therapy in patients with atrial fibrillation randomized earlier versus later after index coronary event: Insights from the AUGUSTUS Trial Presenter: Alexander Fanaroff September 17, 2022
Presentation TCT 2022 Hybrid Interventional Approach (DCB + DES): Clinical Indications, Available Data and Future Perspectives Presenter: Bruno Scheller September 17, 2022
Presentation TCT 2022 Stent-Free PCI (DCB Only Approach): Insights and Considerations from the SELUTION de NOVO Randomized Control Study Presenter: Christian M. Spaulding September 17, 2022
Presentation TCT 2022 Management of Coronary Artery Disease in CLTI? Is That the Ticket? Presenter: Christopher Zarins September 17, 2022
Presentation TCT 2022 TCT 56: Long-term outcomes after bioresorbable vascular scaffold implantation in patients with de-novo coronary artery disease. Presenter: Marta Konopko September 17, 2022
Presentation TCT 2022 TCT 19: Thrombin Generation and Endothelial Progenitor Cell Function in Patients with Acute Myocardial Infarction Treated with Prasugrel versus Ticagrelor Presenter: Mark Kheifets September 17, 2022
Presentation TCT 2022 Management of Concomitant Coronary Disease in AVR-Eligible Patients – COMPLEAT or NOT? Presenter: David Wood September 17, 2022
Presentation TCT 2022 Case #3: Symptomatic Microvascular Disease Presenter: Nils Johnson September 17, 2022
Presentation TCT 2022 Sirolimus DCBs: Technological Trends, Challenges and Advantages Presenter: Ron Waksman September 17, 2022
Presentation TCT 2022 TCT 798: What Is True May Not Be True Presenter: Ki Fung Cliff Li September 17, 2022
Presentation TCT 2022 TCT 733: "Collateral" Damage: Uncovering the Etiology of Chest Pain Presenter: Tushar Ramesh September 17, 2022
Presentation TCT 2022 TCT 69: Impella use for fulminant myocarditis in cardiogenic shock: Analysis of the Japan Registry for Percutaneous Ventricular Assist Device (J-PVAD) Presenter: Koichi Toda September 17, 2022
Presentation TCT 2022 TCT 38: Impact of Smoking on Outcomes in Patients with ST-Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention Presenter: Marta Bujak September 17, 2022
Presentation TCT 2022 Sirolimus Coated DCB in All-Comers EASTBOURNE (MagicTouch DCB) Presenter: Bernardo Cortese September 17, 2022
Presentation TCT 2022 TCT 65: Pulmonary Artery Catheter Use is Associated with Lower Mortality in Cardiogenic Shock, Especially among Patients with Heart Failure Presenter: Navin Kapur September 17, 2022
Presentation TCT 2022 TCT 37: Impact of Right Ventricular Failure on The Outcomes of Acute Inferior Wall Myocardial Infarction Presenter: Antony Anandaraj September 17, 2022